Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ: REGN )

463.05 USD +12.48 (+2.77%)
Official Closing Price Updated: 7:42 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 856,836
Open 454.49
Bid (Size) 461.00 (2)
Ask (Size) 464.89 (1)
Prev. Close 450.57
Today's Range 453.83 - 463.85
52wk Range 418.01 - 664.64
Shares Outstanding 105,949,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma
From PR Newswire
EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
From PR Newswire

Performance

YTD
-4.10%
-4.10%
1 Month
-8.10%
-8.10%
3 Month
-10.27%
-10.27%
6 Month
-25.31%
-25.31%
1 Year
-0.37%
-0.37%

More News

Read More
Independent Data Monitoring Committee Finds Clear Efficacy for REGEN-COV™ (casirivimab with imdevimab) in Phase 3 COVID-19 Outpatient Outcomes Trial
From PR Newswire
Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies
From PR Newswire
Noteworthy Monday Option Activity: RAD, REGN, HURN
Tags Stocks
From Market News Video
Regeneron's Single-Dose REGN1908-1909 Shows Rapid, Durable Benefit In Cat-Allergic Asthma Patients
Tags Biotech News FDA
From Benzinga
Regeneron's COVID-19 Antibody Cocktail Wins EU Positive Opinion
Tags RHHBF Market News Health Care
From Benzinga
First Week of REGN August 20th Options Trading
Tags Stocks
From Market News Video
Akari Therapeutics' PASylated Nomacopan Shows Promising Action In Animal Studies
Tags Benzinga Market News Health Care
From Benzinga
Regeneron To Stop Giving Placebo In COVID-19 Antibody Trial After 'Clear Efficacy'
Tags IDMC Biotech News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.